SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
IVD Solutions
Menu
HIVASE 1+2 (Anti-HIV 1+2)
Direct sandwich ELISA qualitative assay for HIV-1/2 antibodies. 50 µL sample. 90-minute test. Certified by TFDA. Reliable screening tool for HIV antibody detection.
USEFUL RESOURCES
Add to List
>  PRODUCT DESCRIPTION>  SPECIFICATION>  ORDERING INFORMATION
PRODUCT DESCRIPTION
This in vitro diagnostic ELISA assay is designed for qualitative detection of antibodies to HIV-1 and/or HIV-2 in human serum or plasma. The test uses a direct sandwich ELISA format with a 96-well microplate, a specimen volume of 50 µL, and an incubation time of 90 minutes, read at 450 nm. Certified by TFDA (Taiwan), it provides reliable HIV antibody screening. A Non-Reactive result indicates no detectable HIV-1/2 antibodies; Reactive indicates presence of antibodies and should be interpreted with clinical correlation.
SPECIFICATION
Number of wells96
PrincipleDirect Sandwich
Assay formatQualitative
Total incubation time90 minutes
Sample typeSerum / Plasma
Sample volume50 μL
Reading wavelength450nm
Storage2-8°C
CertificationTFDA 
ORDERING INFORMATION
Catalogue No.Product
4HIV3GB HIVASE 1+2 (HIV 1+2)-96 - 96T
4HIV11GB HIVASE 1+2 (HIV 1+2)-480 - 480T